BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15994929)

  • 1. Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.
    Manavathi B; Nair SS; Wang RA; Kumar R; Vadlamudi RK
    Cancer Res; 2005 Jul; 65(13):5571-7. PubMed ID: 15994929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional implications of altered subcellular localization of PELP1 in breast cancer cells.
    Vadlamudi RK; Manavathi B; Balasenthil S; Nair SS; Yang Z; Sahin AA; Kumar R
    Cancer Res; 2005 Sep; 65(17):7724-32. PubMed ID: 16140940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.
    Rajhans R; Nair S; Holden AH; Kumar R; Tekmal RR; Vadlamudi RK
    Cancer Res; 2007 Jun; 67(11):5505-12. PubMed ID: 17545633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
    Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
    Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) interacts with PELP1 and activates MAPK.
    Rayala SK; Hollander Pd; Balasenthil S; Molli PR; Bean AJ; Vadlamudi RK; Wang RA; Kumar R
    J Biol Chem; 2006 Feb; 281(7):4395-403. PubMed ID: 16352611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.
    Chakravarty D; Nair SS; Santhamma B; Nair BC; Wang L; Bandyopadhyay A; Agyin JK; Brann D; Sun LZ; Yeh IT; Lee FY; Tekmal RR; Kumar R; Vadlamudi RK
    Cancer Res; 2010 May; 70(10):4092-101. PubMed ID: 20460518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.
    Nair SS; Mishra SK; Yang Z; Balasenthil S; Kumar R; Vadlamudi RK
    Cancer Res; 2004 Sep; 64(18):6416-23. PubMed ID: 15374949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.
    Balasenthil S; Vadlamudi RK
    J Biol Chem; 2003 Jun; 278(24):22119-27. PubMed ID: 12682072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR.
    Vadlamudi RK; Kumar R
    Nucl Recept Signal; 2007 May; 5():e004. PubMed ID: 17525794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor regulation of estrogen receptor coregulator PELP1 functions via Protein Kinase A pathway.
    Nagpal JK; Nair S; Chakravarty D; Rajhans R; Pothana S; Brann DW; Tekmal RR; Vadlamudi RK
    Mol Cancer Res; 2008 May; 6(5):851-61. PubMed ID: 18505929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging significance of ER-coregulator PELP1/MNAR in cancer.
    Nair S; Vadlamudi RK
    Histol Histopathol; 2007 Jan; 22(1):91-6. PubMed ID: 17128415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.
    Rajhans R; Nair HB; Nair SS; Cortez V; Ikuko K; Kirma NB; Zhou D; Holden AE; Brann DW; Chen S; Tekmal RR; Vadlamudi RK
    Mol Endocrinol; 2008 Mar; 22(3):649-64. PubMed ID: 18079323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase-mediated phosphorylation plays a critical role in the oncogenic functions of PELP1.
    Nair BC; Nair SS; Chakravarty D; Challa R; Manavathi B; Yew PR; Kumar R; Tekmal RR; Vadlamudi RK
    Cancer Res; 2010 Sep; 70(18):7166-75. PubMed ID: 20807815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions.
    Björnström L; Sjöberg M
    Mol Endocrinol; 2002 Oct; 16(10):2202-14. PubMed ID: 12351686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains.
    Choi YB; Ko JK; Shin J
    J Biol Chem; 2004 Dec; 279(49):50930-41. PubMed ID: 15456770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.
    Vadlamudi RK; Balasenthil S; Broaddus RR; Gustafsson JA; Kumar R
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6130-8. PubMed ID: 15579769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.
    Vadlamudi RK; Wang RA; Mazumdar A; Kim Y; Shin J; Sahin A; Kumar R
    J Biol Chem; 2001 Oct; 276(41):38272-9. PubMed ID: 11481323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of aromatase induction by nuclear receptor coregulator PELP1.
    Vadlamudi RK; Rajhans R; Chakravarty D; Nair BC; Nair SS; Evans DB; Chen S; Tekmal RR
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):211-8. PubMed ID: 19800002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
    Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PELP1: Structure, biological function and clinical significance.
    Sareddy GR; Vadlamudi RK
    Gene; 2016 Jul; 585(1):128-134. PubMed ID: 26997260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.